Alexandria Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$6.05M Buy
16,232
+5
+0% +$1.9K 0.56% 67
2021
Q2
$6.2M Sell
16,227
-774
-5% -$296K 0.57% 63
2021
Q1
$6.1M Sell
17,001
-151
-0.9% -$48.6K 0.62% 63
2020
Q4
$5.51M Sell
17,152
-656
-4% -$201K 0.58% 67
2020
Q3
$4.78M Sell
17,808
-44
-0.2% -$11.8K 0.57% 61
2020
Q2
$4.7M Buy
17,852
+490
+3% +$131K 0.61% 56
2020
Q1
$3.94M Buy
17,362
+3,301
+23% +$900K 0.65% 47
2019
Q4
$4.25M Sell
14,061
-35
-0.2% -$9.63K 0.57% 57
2019
Q3
$3.38M Buy
14,096
+60
+0.4% +$16.4K 0.5% 71
2019
Q2
$3.96M Sell
14,036
-418
-3% -$114K 0.56% 56
2019
Q1
$4.15M Sell
14,454
-454
-3% -$131K 0.6% 49
2018
Q4
$3.92M Sell
14,908
-497
-3% -$137K 0.64% 41
2018
Q3
$4.22M Sell
15,405
-410
-3% -$106K 0.62% 50
2018
Q2
$3.76M Sell
15,815
-2,125
-12% -$492K 0.56% 61
2018
Q1
$3.94M Sell
17,940
-565
-3% -$133K 0.58% 57
2017
Q4
$4.16M Buy
+18,505
New +$3.94M 0.61% 55

Other funds holding ELV

Alexandria Capital's ELV Position: Q3 2021 in Review

Alexandria Capital increased its Elevance Health (ELV) stake by 0.03% in Q3 2021, buying an estimated $1.9K and bringing the position to 16,232 shares worth $6.05M. The position accounts for 0.56% of the portfolio, ranked #67.

Alexandria Capital first reported a position in ELV in Q4 2017 and has held it in 16 quarters since. The position peaked at $6.2M in Q2 2021. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • Alexandria Capital held 16,232 shares of Elevance Health worth $6.05M as of Q3 2021.
  • Alexandria Capital bought 5 Elevance Health shares in Q3 2021, an estimated $1.9K.
  • Elevance Health made up 0.56% of Alexandria Capital's portfolio in Q3 2021, its #67 holding.
  • Alexandria Capital first reported a position in Elevance Health in Q4 2017 and has held it in 16 quarters since.
  • Alexandria Capital's Elevance Health position peaked at $6.2M in Q2 2021.
  • 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.